MetaVia Inc.

NASDAQ: MTVA · Healthcare · Biotechnology

PublicHQ Cambridge, MA · MiddlesexCIK 0001638287Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH 27DQ —GM —SS 37

v0.1 · 35/100 weight · pillars only

↑ filing timeliness, balance-sheet leverage · ↓ Piotroski F, return on equity

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$13.0M

Employees

as of 2026-08-24

Market cap

$3.2M

as of 2026-08-24

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$13.0M-$13.0M2025

Operating income-$13.7M-$13.7M2025

Total assets$11.1M$11.1M2025

Liabilities$5.8M$5.8M2025

Equity$5.3M$5.3M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is MetaVia Inc.’s financial profile?

MetaVia Inc. earned -$13.0M in FY2025 net income.

Peers · Healthcare

KMA Holding, Inc.——Cann American Corp.——CTT Pharmaceutical Holdings, Inc.——Standard Dental Labs Inc.——TransCode Therapeutics, Inc.——Enzolytics Inc.——

Neighbors

Middlesex →

GE Vernova Inc.$38.1B63C Thermo Fisher Scientific Inc.$44.6B86A Analog Devices, Inc.$11.0B87A The TJX Companies, Inc.$60.4B85A Boston Scientific Corporation$20.1B88A Symbotic Inc.$2.2B49D

Key facts

CEOHyung Heon Kim

SectorHealthcare

IndustryBiotechnology

HeadquartersCambridge, MA

ExchangeNASDAQ: MTVA

Employees8

IPO date2016-08-05

Latest filings

10-Q2026-08-06 8-K2026-08-06 8-K2026-07-09 8-K2026-07-02 8-K2026-06-08 8-K2026-06-08 8-K2026-05-27 8-K2026-05-18

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.